Статті в журналах з теми "FOOD AND DRUGS ADMINISTRATION"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "FOOD AND DRUGS ADMINISTRATION".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Hutcheon, Duncan E. "Drugs Approved by Food & Drug Administration." Journal of Clinical Pharmacology 29, no. 5 (May 1989): 478–79. http://dx.doi.org/10.1002/j.1552-4604.1989.tb03366.x.
Повний текст джерелаFurlan, Anthony J., and Marc Fisher. "Devices, Drugs, and the Food and Drug Administration." Stroke 36, no. 2 (February 2005): 398–99. http://dx.doi.org/10.1161/01.str.0000153057.07181.94.
Повний текст джерелаTsimberidou, Apostolia-Maria, Fadi Braiteh, David J. Stewart, and Razelle Kurzrock. "Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial." Journal of Clinical Oncology 27, no. 36 (December 20, 2009): 6243–50. http://dx.doi.org/10.1200/jco.2009.23.6018.
Повний текст джерелаHaffner, Marlene E., and John V. Kelsey. "Evaluation of Orphan Products by the U.S. Food and Drug Administration." International Journal of Technology Assessment in Health Care 8, no. 4 (1992): 647–57. http://dx.doi.org/10.1017/s0266462300002348.
Повний текст джерелаRangaraj, Nagarjun, Sunitha Sampathi, Vijayabhaskarreddy Junnuthula, Praveen Kolimi, Preethi Mandati, Sagar Narala, Dinesh Nyavanandi, and Sathish Dyawanapelly. "Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects." Pharmaceutics 14, no. 9 (August 27, 2022): 1807. http://dx.doi.org/10.3390/pharmaceutics14091807.
Повний текст джерелаKharitonovа, L. A., A. M. Zaprudnov, and K. I. Grigoriev. "Mandatory assessment of trophological status and nutrition in children in drugs prescribing." Experimental and Clinical Gastroenterology, no. 1 (May 2, 2020): 4–14. http://dx.doi.org/10.31146/1682-8658-ecg-173-1-4-14.
Повний текст джерелаSharma, Ajitha, and Rathnakar Up. "REVISED FOOD AND DRUG ADMINISTRATION RISK CATEGORIES OF DRUGS DURING PREGNANCY." Asian Journal of Pharmaceutical and Clinical Research 10, no. 7 (July 1, 2017): 77. http://dx.doi.org/10.22159/ajpcr.2017.v10i7.16539.
Повний текст джерелаButler, O. D., Woodrow M. Knight, and Jack C. Taylor. "The Regulation of Production Drugs by the Food and Drug Administration." Professional Animal Scientist 2, no. 1 (June 1986): 14–17. http://dx.doi.org/10.15232/s1080-7446(15)32415-3.
Повний текст джерелаBlankfield, Robert P., and Imran H. Iftikhar. "Food and Drug Administration Regulation of Drugs That Raise Blood Pressure." Journal of Cardiovascular Pharmacology and Therapeutics 20, no. 1 (May 6, 2014): 5–8. http://dx.doi.org/10.1177/1074248414531852.
Повний текст джерелаAshley, Donald D. "Clarifying Misconceptions About US Food and Drug Administration Unapproved Drugs Program." Anesthesia & Analgesia 127, no. 6 (December 2018): 1292–94. http://dx.doi.org/10.1213/ane.0000000000003852.
Повний текст джерелаSukhatme, Vidula V., Suresh S. Ramalingam, Rafi Ahmed, and Vikas P. Sukhatme. "Repurposing Food and Drug Administration–Approved Drugs to Promote Antitumor Immunity." Cancer Journal 25, no. 2 (2019): 88–99. http://dx.doi.org/10.1097/ppo.0000000000000368.
Повний текст джерелаOfosu, Frederick A. "The United States Food and Drugs Administration Approves a Generic Enoxaparin." Clinical and Applied Thrombosis/Hemostasis 17, no. 1 (December 15, 2010): 5–8. http://dx.doi.org/10.1177/1076029610389028.
Повний текст джерелаYao, Hsien-Tsung, Jia-Hsuan Lin, Yun-Ta Liu, Mei-Ling Li, and Wenchang Chiang. "Food–Drug Interaction between the Adlay Bran Oil and Drugs in Rats." Nutrients 11, no. 10 (October 15, 2019): 2473. http://dx.doi.org/10.3390/nu11102473.
Повний текст джерелаTao, Rachel E., Stuti Prajapati, Jessica N. Pixley, Ayman Grada, and Steven R. Feldman. "Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy." Antibiotics 12, no. 7 (July 5, 2023): 1152. http://dx.doi.org/10.3390/antibiotics12071152.
Повний текст джерелаS, Shidhaye. "Effect of Food on Bioavailability of Drug through Gastro-Retentive Drug Delivery System." Bioequivalence & Bioavailability International Journal 5, no. 1 (2021): 1–3. http://dx.doi.org/10.23880/beba-16000148.
Повний текст джерелаLloyd, Rhea, Jennifer Harris, Sonal Wadhwa, and Wiley Chambers. "Food and Drug Administration approval process for ophthalmic drugs in the US." Current Opinion in Ophthalmology 19, no. 3 (May 2008): 190–94. http://dx.doi.org/10.1097/icu.0b013e3282f97fa1.
Повний текст джерелаde La Garza, René, and Chris E. Johanson. "The effects of food deprivation on the self-administration of psychoactive drugs." Drug and Alcohol Dependence 19, no. 1 (January 1987): 17–27. http://dx.doi.org/10.1016/0376-8716(87)90083-4.
Повний текст джерелаNasr, Alexander, Thomas J. Lauterio, and Matthew W. Davis. "Unapproved drugs in the united states and the food and drug administration." Advances in Therapy 28, no. 10 (September 1, 2011): 842–56. http://dx.doi.org/10.1007/s12325-011-0059-4.
Повний текст джерелаHwang, Thomas J., Jessica M. Franklin, Christopher T. Chen, Julie C. Lauffenburger, Bishal Gyawali, Aaron S. Kesselheim, and Jonathan J. Darrow. "Efficacy, Safety, and Regulatory Approval of Food and Drug Administration–Designated Breakthrough and Nonbreakthrough Cancer Medicines." Journal of Clinical Oncology 36, no. 18 (June 20, 2018): 1805–12. http://dx.doi.org/10.1200/jco.2017.77.1592.
Повний текст джерелаKaplan, Robert M., Amanda J. Koong, and Veronica Irvin. "Review of Evidence Supporting 2022 US Food and Drug Administration Drug Approvals." JAMA Network Open 6, no. 8 (August 8, 2023): e2327650. http://dx.doi.org/10.1001/jamanetworkopen.2023.27650.
Повний текст джерелаWard, Robert M. "Children, Drugs, and the Food and Drug Administration: Studies of Pediatric Drugs Are Beginning to Catch Up." Pediatric Annals 30, no. 4 (April 1, 2001): 189–94. http://dx.doi.org/10.3928/0090-4481-20010401-06.
Повний текст джерелаTibau, Ariadna, Alberto Ocana, Geòrgia Anguera, Bostjan Seruga, Arnoud J. Templeton, Agustí Barnadas, and Eitan Amir. "Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration." JAMA Oncology 2, no. 6 (June 1, 2016): 744. http://dx.doi.org/10.1001/jamaoncol.2015.6479.
Повний текст джерелаMolto, Consolacion, Thomas J. Hwang, Marta Andres, Maria Borrell, Ignasi J. Gich Saladich, Agust Barnadas, Eitan Amir, Aaron S. Kesselheim, and Ariadna Tibau Martorell. "Clinical benefit of breakthrough cancer drugs approved by the United States Food and Drug Administration." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 6513. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.6513.
Повний текст джерелаKayki-Mutlu, Gizem, and Martin C. Michel. "A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020." Naunyn-Schmiedeberg's Archives of Pharmacology 394, no. 5 (April 16, 2021): 839–52. http://dx.doi.org/10.1007/s00210-021-02085-3.
Повний текст джерелаAebersold, Paul. "FDA Experience with Medical Countermeasures under the Animal Rule." Advances in Preventive Medicine 2012 (2012): 1–11. http://dx.doi.org/10.1155/2012/507571.
Повний текст джерелаBasin, Bhawna. "New Drugs for Breast Cancer Treatment." TEXILA INTERNATIONAL JOURNAL OF ACADEMIC RESEARCH 10, no. 3 (July 28, 2023): 26–33. http://dx.doi.org/10.21522/tijar.2014.10.03.art003.
Повний текст джерелаChhim, Rebecca F., Chasity M. Shelton, and Michael L. Christensen. "Recent New Drug Approvals, Part 2: Drugs Undergoing Active Clinical Studies in Children." Journal of Pediatric Pharmacology and Therapeutics 18, no. 1 (January 1, 2013): 14–38. http://dx.doi.org/10.5863/1551-6776-18.1.14.
Повний текст джерелаAyele, Yohanes, Abraham Nigussie Mekuria, Assefa Tola, Kirubel Minsamo Mishore, and Fisseha Bonja Geleto. "Prescription drugs use during pregnancy in Ethiopia: A systematic review and meta-analysis." SAGE Open Medicine 8 (January 2020): 205031212093547. http://dx.doi.org/10.1177/2050312120935471.
Повний текст джерелаBoozalis, Emily, Yevgeniy R. Semenov, and Shawn G. Kwatra. "Food and drug administration approval process for dermatology drugs in the United States." Journal of Dermatological Treatment 29, no. 6 (January 26, 2018): 536–38. http://dx.doi.org/10.1080/09546634.2018.1425361.
Повний текст джерелаJohnson, John R., Grant Williams, and Richard Pazdur. "End Points and United States Food and Drug Administration Approval of Oncology Drugs." Journal of Clinical Oncology 21, no. 7 (April 1, 2003): 1404–11. http://dx.doi.org/10.1200/jco.2003.08.072.
Повний текст джерелаSarvas, Holly, Benjamin Carlisle, Samantha Dolter, Esther Vinarov, and Jonathan Kimmelman. "Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer." JNCI: Journal of the National Cancer Institute 112, no. 8 (November 13, 2019): 859–62. http://dx.doi.org/10.1093/jnci/djz212.
Повний текст джерелаda la Torre, Beatriz G., and Fernando Albericio. "Practical Protocols for Solid-Phase Peptide Synthesis 4.0." Methods and Protocols 5, no. 6 (October 24, 2022): 85. http://dx.doi.org/10.3390/mps5060085.
Повний текст джерелаChambers, James D., Katherine A. Clifford, Daniel E. Enright, and Peter J. Neumann. "Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act." JAMA Network Open 6, no. 8 (August 15, 2023): e2329006. http://dx.doi.org/10.1001/jamanetworkopen.2023.29006.
Повний текст джерелаBateman-House, Alison, Arthur Caplan, and Lisa Kearns. "Ensuring Justice in Access to Investigational Neurological Drugs." Seminars in Neurology 38, no. 05 (October 2018): 583–88. http://dx.doi.org/10.1055/s-0038-1668076.
Повний текст джерелаRomanach, John, and Walter E. Block. "Medical Economics: End the FDA (Food and Drug Administration)." Winners 18, no. 1 (March 31, 2017): 43. http://dx.doi.org/10.21512/tw.v18i1.4052.
Повний текст джерелаPearson, Kay C., and Dianne L. Kennedy. "Adverse Drug Reactions and the Food and Drug Administration." Journal of Pharmacy Practice 2, no. 4 (August 1989): 209–13. http://dx.doi.org/10.1177/089719008900200403.
Повний текст джерелаTu, S. Sean, Aaron S. Kesselheim, Kathrine Wetherbee, and William B. Feldman. "Changes in the Number of Continuation Patents on Drugs Approved by the FDA." JAMA 330, no. 5 (August 1, 2023): 469. http://dx.doi.org/10.1001/jama.2023.11525.
Повний текст джерелаKitchlew, Rizwana, Miqdad Haider, and Saba Mir. "Awareness about appropriate practice of Sodium Polystyrene Sulfonate administration." Professional Medical Journal 27, no. 01 (January 10, 2020): 52–56. http://dx.doi.org/10.29309/tpmj/2019.27.01.3184.
Повний текст джерелаGreenlees, Kevin J. "Animal Drug Human Food Safety Toxicology and Antimicrobial Resistance—The Square Peg." International Journal of Toxicology 22, no. 2 (March 2003): 131–34. http://dx.doi.org/10.1080/10915810305091.
Повний текст джерелаNaci, Huseyin, Robin Forrest, Mike Zhai, Amanda R. Stofesky, and Aaron S. Kesselheim. "Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D." JAMA Health Forum 4, no. 2 (February 24, 2023): e225610. http://dx.doi.org/10.1001/jamahealthforum.2022.5610.
Повний текст джерелаDhodapkar, Meera M., Joseph S. Ross, and Reshma Ramachandran. "US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019." JAMA Network Open 6, no. 6 (June 26, 2023): e2318889. http://dx.doi.org/10.1001/jamanetworkopen.2023.18889.
Повний текст джерелаMason, Marlys J. "Drugs or Dietary Supplements: FDA's Enforcement of DSHEA." Journal of Public Policy & Marketing 17, no. 2 (September 1998): 296–302. http://dx.doi.org/10.1177/074391569801700212.
Повний текст джерелаSalman, Mohammad, Syed Allahsan, Manzoor Mahmood, Md Khairul Anam, Shahed Mohammad Anwar, Roksana Afrose, Md Abu Afrose, Md Ashraf Uddin Sultan, and Fazlur Rahman. "New Drugs for Acute Heart Failure." University Heart Journal 7, no. 1 (March 29, 2012): 35–38. http://dx.doi.org/10.3329/uhj.v7i1.10208.
Повний текст джерелаFricker, Lloyd D. "Proteasome Inhibitor Drugs." Annual Review of Pharmacology and Toxicology 60, no. 1 (January 6, 2020): 457–76. http://dx.doi.org/10.1146/annurev-pharmtox-010919-023603.
Повний текст джерелаHermida, Laura G., Manuel Sabés-Xamaní, and Ramon Barnadas-Rodríguez. "Characteristics and behaviour of liposomes when incubated with natural bile salt extract: implications for their use as oral drug delivery systems." Soft Matter 10, no. 35 (2014): 6677–85. http://dx.doi.org/10.1039/c4sm00981a.
Повний текст джерелаCupic, Vitomir, Sasa Ivanovic, Suncica Borozan, Indira Mujezinovic, Dejana Cupic-Miladinovic, and Jelena Aleksic. "Antimicrobial agents in laying hens." Zbornik Matice srpske za prirodne nauke, no. 142 (2022): 61–71. http://dx.doi.org/10.2298/zmspn2242061c.
Повний текст джерелаPivarnik, Greg. "Cells as Drugs?: Regulating the Future of Medicine." American Journal of Law & Medicine 40, no. 2-3 (June 2014): 298–321. http://dx.doi.org/10.1177/009885881404000208.
Повний текст джерелаSmetana, Gerald W. "Update on Novel Drugs for Primary Care Practice: Drugs Approved by the U.S. Food and Drug Administration in 2015." Annals of Internal Medicine 164, no. 9 (May 3, 2016): W48. http://dx.doi.org/10.7326/m15-3104.
Повний текст джерелаBaldwin, Paul. "The Regulation of Dietary Supplements in the United States." Senior Care Pharmacist 37, no. 8 (August 1, 2022): 374. http://dx.doi.org/10.4140/tcp.n.2022.374.
Повний текст джерелаMilutinov, Jovana, Veljko Krstonošić, Dejan Ćirin, and Nebojša Pavlović. "Emulgels: Promising Carrier Systems for Food Ingredients and Drugs." Polymers 15, no. 10 (May 13, 2023): 2302. http://dx.doi.org/10.3390/polym15102302.
Повний текст джерела